1 Result

People

  1. Bello
    Bello
  2. Drullinsky
    Drullinsky
  3. Hassoun
    Hassoun
  4. Hoover
    Hoover
  5. Jhanwar
    Jhanwar
  6. Landau
    Landau
  7. Lendvai
    Lendvai
  8. Lesokhin
    Lesokhin
  9. Nimer
    Nimer
  10. Pandit-Taskar
    Pandit-Taskar

Groups

  1. Bone Marrow Transplant (1)
  2. Breast Medicine Service (1)
  3. Center for Hematologic Malignancies (1)
  4. Department of Medicine (1)
  5. Hematologic Malignancies Research (1)
  6. Hematologic Malignancies, Division of (1)
  7. Molecular Imaging and Therapy Service (1)
  8. Myeloma (1)
  9. Radiology, Department of (1)
  10. Solid Tumor Oncology Division (1)
  1. "adult"
  2. "Hani Hassoun"
  3. "Philip Schulman"
Formats
  1. Journal Article (1)
Groups
  1. Bone Marrow Transplant (1)
  2. Breast Medicine Service (1)
  3. Center for Hematologic Malignancies (1)
  4. Department of Medicine (1)
  5. Hematologic Malignancies Research (1)
  6. Hematologic Malignancies, Division of (1)

More Groups

People
  1. Alexander Lesokhin (1)
  2. Christina Bello (1)
  3. Elizabeth Hoover (1)
  4. Elyn Stubblefield (1)
  5. Hani Hassoun (1)
  6. Heather Landau (1)

More People

Years
  1. 2012 (1)
Publications
  1. Leukemia and Lymphoma (1)
Publishers
  1. Taylor & Francis Group (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease
    Journal Article

    Landau, H.; Pandit-Taskar, N.; Hassoun, H.; Cohen, A.; Lesokhin, A.; Lendvai, N.; Drullinsky, P.; Schulman, P.; Jhanwar, S.; Hoover, E.; more...
    Leukemia and Lymphoma (2012)

    Fulltext@MSK | Save